Advertisement

Topics

Biotechnology Products Reports

00:50 EDT 25th April 2017 | BioPortfolio

Celltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 16032017] Prices from USD $250

SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody bios...

Protagen Protein Services GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 21022017] Prices from USD $250

SummaryProtagen Protein Services GmbH PPS, a subsidiary of Zukunftsfonds Heilbronn GmbH Co KG, is a contract research organization that focuses on protein analytics. The company offers services including protein characterization, services for biopharmaceuticals, biosimilars services and analytical methods. Its protein characterization services include protein quantification, protein primary struc...

Aeglea BioTherapeutics Inc AGLE Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryAeglea BioTherapeutics Inc Aeglea BioTherapeutics, formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops engineered human enzymes and companion diagnostics for the treatment of cancer. The company by combining amino acid depletion therapy with codevelopment of diagnostics has identified the metabolic reprogramming of cancer as an opportunity with improved th...

Celltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody bios...

Protagen Protein Services GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryProtagen Protein Services GmbH PPS, a subsidiary of Zukunftsfonds Heilbronn GmbH Co KG, is a contract research organization that focuses on protein analytics. The company offers services including protein characterization, services for biopharmaceuticals, biosimilars services and analytical methods. Its protein characterization services include protein quantification, protein primary struc...

Global Biosimilar Market Trends Opportunities: 2015 Edition Prices from USD $800

Scope of the ReportThe report titled Global Biosimilar Market: Trends Opportunities 2015 Edition analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilar...

GlobalOncologyBiosimilars Market 20162020 Prices from USD $3000

About Oncology BiosimilarsCancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting. Biosimilars are synthesized with the use of biologic components s...

RegeneRx Biopharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.Project Description:Datamonitors' RegeneRx Biopharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report in...

Cantab Biopharmaceuticals Limited formerly Cambridge Biomanufacturing Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Cantab Biopharmaceuticals Limited formerly Cambridge Biomanufacturing Limited Mergers Acquisitions MA, Partnerships Alliances and Investmen...

Inspiration Biopharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Inspiration Biopharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, ...

Global Biosimilars Market 20162020 Prices from USD $2500

About BiosimilarsBiosimilars are defined as the followon versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator's product. They have many similarities, but are not identical to, the r...

Oxygen Biotherapeutics, Inc. formerly Synthetic Blood International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Oxygen Biotherapeutics, Inc. formerly Synthetic Blood International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments r...

Global Solid Tumors Drugs Market 20162020 Prices from USD $2500

About the Solid Tumors Drugs MarketThe rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors. Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant cancerous or benign not cancer...

BIOSIMILARS Regulatory Framework and Pipeline Analysis Prices from USD $2995

BIOSIMILARS Regulatory Framework and Pipeline AnalysisSummaryBiosimilars are copied versions of biologics that offer a 2050% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. All the countrie...

Talecris Biotherapeutics Holdings Corp. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.Project Description:Datamonitors' Talecris Biotherapeutics Holdings Corp. Mergers Acquisitions MA, Partnerships Alliances and Investments rep...

GTC Biotherapeutics, Inc. formerly Genzyme Transgenics Corp. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' GTC Biotherapeutics, Inc. formerly Genzyme Transgenics Corp. Mergers Acquisitions MA, Partnerships Alliances and Investments report include...

Intas Biopharmaceuticals Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Intas Biopharmaceuticals Limited Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, deta...

CardioVascular BioTherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.Project Description:Datamonitors' CardioVascular BioTherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report...

Juvaris BioTherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Juvaris BioTherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detaile...

Global Immunotherapy Drugs 20162020 Prices from USD $2500

About Immunotherapy DrugsImmunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully fighting diseases such as cancer, respiratory, infectious, and autoimmune disorders.Technavio's analysts forecast the global immunotherapy drugs market to grow at a CAGR of 11.52% during the period 20...

Genova Biotherapeutics, Inc. formerly Kinder Travel, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Genova Biotherapeutics, Inc. formerly Kinder Travel, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes b...

Biota Pharmaceuticals, Inc. formerly Nabi Biopharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' Biota Pharmaceuticals, Inc. formerly Nabi Biopharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report i...

Aeglea BioTherapeutics, Inc. AGLE Financial and Strategic SWOT Analysis Review Prices from USD $300

SummaryAeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops engineered human enzymes and companion diagnostics for the treatment of cancer. The company by combining amino acid depletion therapy with codevelopment of diagnostics has identified the metabolic reprogramming of cancer as an opportunity with improved ...

amp biosimilars AG 1YA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

Summaryamp biosimilars AG amp biosimilars is a biopharmaceutical company that develops biosimilars. Its product pipeline includes four biosimilar development projects focusing on immune disorders and cancer. The company focuses on clinical areas that include cancer, autoimmune and inflammatory diseases. The company combines a research platform with the most advanced analytics, process science, and...

Celltrion, Inc. 068270 Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryCelltrion, Inc. Celltrion is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody bi...

Quick Search
Advertisement
 

review and buy Biotechnology Products market research data and corporate reports here